Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metastatic Breast Cancer in Austria

NCT03870620 is registered in ClinicalTrials.gov with Arbeitsgemeinschaft medikamentoese Tumortherapie as lead sponsor.

NCT NCT03870620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03870620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metastatic Breast Cancer in Austria
Lead sponsor
Arbeitsgemeinschaft medikamentoese Tumortherapie
Phase
Observational
Overall status
Recruiting
Start date
June 15, 2015
Completion date
June 30, 2025
Enrollment
5,000 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast carcinoma, breast tumor